"Tracking tumor changes over time is an important part of understanding how a patient is responding to treatment. Tools such as InferCare RECIST can help physicians use AI to track and measure lesions across multiple CT studies, providing a more consistent view of disease progression and treatment response throughout the course of care."
When a patient undergoes a follow-up scan, the current and prior studies are automatically sent to InferCare RECIST for analysis.
InferCare RECIST performs interactive lesion detection, followed by automated segmentation, measurement, and registration, ensuring consistent and reproducible quantification across studies.
The system automatically co-registers each lesion across all available scans for the patient. Compared with the traditional workflow—where radiologists must open multiple studies side-by-side, locate the same lesion, and repeat measurements—InferCare RECIST significantly reduces the workload and time required for RECIST 1.1 evaluation.
InferCare RECIST then generates a structured report that includes selected target lesions, non-target lesions, and any newly identified lesions, along with the corresponding RECIST response category.
